QUANTITATIVE ONCOLOGY Paul Spellman, PhD and Joe Gray, PhD, Program Co-Leaders ABSTRACT The Quantitative Oncology (QO) Program is a multi-disciplinary research program that was formed to facilitate the development and application of advanced measurement capabilities from omics to imaging, combined with computational techniques, to improve cancer management. The goal of the QO program is to enable quantitative understanding of the behavior of cancerous cells and tissues as they evolve, respond to therapy, and interact with their microenvironments. The QO program facilitates collaborative science organized around three research themes: 1) Imaging ? focuses on improving the understanding of cancer by analyzing components of tumors on scales from angstrom to centimeters, including proteins to cells to tissues and using this data to inform diagnostics and therapies; 2) Omics ? employing and improving tools to analyze genomes, transcriptomes, and proteomes to enhance our understanding of cancer; and 3) Systems Biology - focuses on elucidation of the emergent properties of cancer-related molecular networks, the molecular and cellular phenotypes they regulate and the evolution/adaptation of these systems during cancer development and treatment. The QO Program is co-led by Paul Spellman, PhD, an expert in the application of translational cancer genomics and systems biology to cancer detection and classification, and Joe Gray, PhD, an expert in systems biomedicine and imaging technologies, with an emphasis on breast and pancreatic cancer. The QO program has 28 members who are drawn from seven basic science departments and four clinical departments in the OHSU School of Medicine, and the Pacific Northwest National Laboratory (PNNL). Annual direct cost funding as of January 2016 amounted to $10,011,427 (total cost), of which $1,833,130 (total cost) was from the NCI and $6,229,652 (total cost) was peer-reviewed. The discoveries made in this program have resulted in 251 publications, of which 31.5% are intra-programmatic collaborations, 43.8% are inter-programmatic collaborations, and 71.3% are inter- institutional.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA069533-21
Application #
9733149
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
21
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Kurtz, Stephen E; Eide, Christopher A; Kaempf, Andy et al. (2018) Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia. Leukemia 32:2025-2028
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Watson, Spencer S; Dane, Mark; Chin, Koei et al. (2018) Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. Cell Syst 6:329-342.e6
Li, Bingbing X; Chen, Jingjin; Chao, Bo et al. (2018) Anticancer Pyrroloquinazoline LBL1 Targets Nuclear Lamins. ACS Chem Biol 13:1380-1387
Hulett, Tyler W; Jensen, Shawn M; Wilmarth, Phillip A et al. (2018) Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination. J Immunother Cancer 6:27
Vranka, Janice A; Staverosky, Julia A; Reddy, Ashok P et al. (2018) Biomechanical Rigidity and Quantitative Proteomics Analysis of Segmental Regions of the Trabecular Meshwork at Physiologic and Elevated Pressures. Invest Ophthalmol Vis Sci 59:246-259
Lane, Ryan S; Lund, Amanda W (2018) Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors. Front Immunol 9:2662
Tyner, Jeffrey W; Tognon, Cristina E; Bottomly, Daniel et al. (2018) Functional genomic landscape of acute myeloid leukaemia. Nature 562:526-531
Risom, Tyler; Langer, Ellen M; Chapman, Margaret P et al. (2018) Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer. Nat Commun 9:3815
Minnier, Jessica; Pennock, Nathan D; Guo, Qiuchen et al. (2018) RNA-Seq and Expression Arrays: Selection Guidelines for Genome-Wide Expression Profiling. Methods Mol Biol 1783:7-33

Showing the most recent 10 out of 277 publications